Myeloid Neoplasm With Eosinophilia and FIP1L1-PDGFRA Rearrangement Treated With Imatinib Mesylate: A Pediatric Case With Long-term Follow-up.

Myeloid Neoplasm With Eosinophilia and FIP1L1-PDGFRA Rearrangement Treated With Imatinib Mesylate: A Pediatric Case With Long-term Follow-up. J Pediatr Hematol Oncol. 2019 May; 41(4):334-335.

View in: PubMed

subject areas

Adolescent
Adolescent
Antineoplastic Agents
Antineoplastic Agents
Eosinophilia
Eosinophilia
Humans
Humans
Imatinib Mesylate
Imatinib Mesylate
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Male
Male
mRNA Cleavage and Polyadenylation Factors
mRNA Cleavage and Polyadenylation Factors
Oncogene Proteins, Fusion
Oncogene Proteins, Fusion
Receptor, Platelet-Derived Growth Factor alpha
Receptor, Platelet-Derived Growth Factor alpha

authors with profiles

Ashley Ann Baker
Anand Srinivasan